These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

513 related articles for article (PubMed ID: 22051430)

  • 1. The role of magnesium in hypertension and cardiovascular disease.
    Houston M
    J Clin Hypertens (Greenwich); 2011 Nov; 13(11):843-7. PubMed ID: 22051430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The future of antihypertensive treatment.
    Israili ZH; Hernández-Hernández R; Valasco M
    Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral magnesium supplementation reduces ambulatory blood pressure in patients with mild hypertension.
    Hatzistavri LS; Sarafidis PA; Georgianos PI; Tziolas IM; Aroditis CP; Zebekakis PE; Pikilidou MI; Lasaridis AN
    Am J Hypertens; 2009 Oct; 22(10):1070-5. PubMed ID: 19617879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of magnesium in the prevention and control of hypertension.
    Ryan MP; Brady HR
    Ann Clin Res; 1984; 16 Suppl 43():81-8. PubMed ID: 6398986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minerals and blood pressure.
    Karppanen H
    Ann Med; 1991 Aug; 23(3):299-305. PubMed ID: 1930921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnesium in hypertension, cardiovascular disease, metabolic syndrome, and other conditions: a review.
    Champagne CM
    Nutr Clin Pract; 2008; 23(2):142-51. PubMed ID: 18390781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potassium magnesium supplementation for four weeks improves small distal artery compliance and reduces blood pressure in patients with essential hypertension.
    Wu G; Tian H; Han K; Xi Y; Yao Y; Ma A
    Clin Exp Hypertens; 2006 Jul; 28(5):489-97. PubMed ID: 16820345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lifestyle modifications to prevent and control hypertension. 6. Recommendations on potassium, magnesium and calcium. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada.
    Burgess E; Lewanczuk R; Bolli P; Chockalingam A; Cutler H; Taylor G; Hamet P
    CMAJ; 1999 May; 160(9 Suppl):S35-45. PubMed ID: 10333852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current treatment of patients with hypertension: therapeutic implications of INSIGHT.
    Taddei S; Ghiadoni L; Salvetti A
    Drugs; 2003; 63(14):1435-44. PubMed ID: 12834362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectively Prescribing Oral Magnesium Therapy for Hypertension: A Categorized Systematic Review of 49 Clinical Trials.
    Rosanoff A; Costello RB; Johnson GH
    Nutrients; 2021 Jan; 13(1):. PubMed ID: 33435187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of dietary salts on the cardiovascular effects of low-dose combination of ramipril and felodipine in spontaneously hypertensive rats.
    Mervaala EM; Malmberg L; Teräväinen TL; Laakso J; Vapaatalo H; Karppanen H
    Br J Pharmacol; 1998 Jan; 123(2):195-204. PubMed ID: 9489606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of magnesium on blood pressure and intracellular ion levels of Brazilian hypertensive patients.
    Sanjuliani AF; de Abreu Fagundes VG; Francischetti EA
    Int J Cardiol; 1996 Oct; 56(2):177-83. PubMed ID: 8894790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrolyte minerals intake and cardiovascular health.
    Mohammadifard N; Gotay C; Humphries KH; Ignaszewski A; Esmaillzadeh A; Sarrafzadegan N
    Crit Rev Food Sci Nutr; 2019; 59(15):2375-2385. PubMed ID: 29543505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial of cardiovascular events in hypertension. Rationale and design.
    Mann J; Julius S
    Blood Press; 1998 May; 7(3):176-83. PubMed ID: 9758088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nutraceuticals and blood pressure control: a European Society of Hypertension position document.
    Borghi C; Tsioufis K; Agabiti-Rosei E; Burnier M; Cicero AFG; Clement D; Coca A; Desideri G; Grassi G; Lovic D; Lurbe E; Kahan T; Kreutz R; Jelakovic B; Polonia J; Redon J; Van De Borne P; Mancia G
    J Hypertens; 2020 May; 38(5):799-812. PubMed ID: 31977574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined calcium, magnesium and potassium supplementation for the management of primary hypertension in adults.
    Beyer FR; Dickinson HO; Nicolson DJ; Ford GA; Mason J
    Cochrane Database Syst Rev; 2006 Jul; (3):CD004805. PubMed ID: 16856060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Hypertension: A Review.
    Carey RM; Moran AE; Whelton PK
    JAMA; 2022 Nov; 328(18):1849-1861. PubMed ID: 36346411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early morning home blood pressure control among treated patients with controlled office blood pressure.
    Zuo HJ; Song XT; Yang HX; Deng LQ; Wang JW
    J Clin Hypertens (Greenwich); 2019 Dec; 21(12):1823-1830. PubMed ID: 31769172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood pressure control and drug therapy in patients with diagnosed hypertension: a survey in Italian general practice.
    Filippi A; Paolini I; Innocenti F; Mazzaglia G; Battaggia A; Brignoli O
    J Hum Hypertens; 2009 Nov; 23(11):758-63. PubMed ID: 19242492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Goals of antihypertensive therapy.
    McVeigh GE; Flack J; Grimm R
    Drugs; 1995 Feb; 49(2):161-75. PubMed ID: 7729325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.